Eli Lilly and Company and Kowa Pharmaceuticals America Reveal Positive Results of PREVAIL US Study

SCOTTSDALE, Ariz., May 31, 2012 /PRNewswire/ -- Kowa Pharmaceuticals America, Inc. and Eli Lilly and Company (NYSE:LLY) today announced results of the PREVAIL U.S. study (Pitavastatin compaREd with pr…
Read the full story: BioSpace.com Featured News